According to the Zhitong Finance App, China Medical Group (08225.HK) announced its 2026 interim results, with revenue of about 22.953 million yuan, an increase of about 6.17% over the previous year. Net profit of 9.496 million yuan, up 9.16% year on year; earnings per share of 0.95 points.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.